A genetic variant in the interleukin 28B gene as a major predictor for sustained virologic response in chronic hepatitis C virus infection.

[1]  P. Tangkijvanich,et al.  Prevalence of Thymine—Adenine Dinucleotide Repeat, IL28B and IFNL4 in Thai Population and Correlation with Spontaneous Clearance and Treatment Outcome of Hepatitis C Infection , 2015, PloS one.

[2]  T. Berg,et al.  Predictive Value of Interferon-Lambda Gene Polymorphisms for Treatment Response in Chronic Hepatitis C , 2014, PloS one.

[3]  L. Prokunina-Olsson,et al.  Association of the IFNL4-ΔG Allele With Impaired Spontaneous Clearance of Hepatitis C Virus. , 2014, The Journal of infectious diseases.

[4]  S. Khakoo,et al.  Genetic Variation in the Interleukin-28B Gene Is Associated with Spontaneous Clearance and Progression of Hepatitis C Virus in Moroccan Patients , 2013, PloS one.

[5]  Barbara Rehermann,et al.  A variant upstream of IFNL3 (IL28B) creating a new interferon gene IFNL4 is associated with impaired clearance of hepatitis C virus , 2013, Nature Genetics.

[6]  A. Burguete-García,et al.  IL28B polymorphisms predict the response to chronic hepatitis C virus infection treatment in a Mexican population. , 2012, Annals of hepatology.

[7]  S. El-Kafrawy,et al.  Genetic polymorphism in IL28B is associated with spontaneous clearance of hepatitis C virus genotype 4 infection in an Egyptian cohort. , 2011, The Journal of infectious diseases.

[8]  J. Pinho,et al.  IL28B polymorphisms are markers of therapy response and are influenced by genetic ancestry in chronic hepatitis C patients from an admixed population , 2011, Liver international : official journal of the International Association for the Study of the Liver.

[9]  M. Silva,et al.  Genetic variation in interleukin-28B predicts SVR in hepatitis C genotype 1 Argentine patients treated with PEG IFN and ribavirin. , 2011, Annals of hepatology.

[10]  Katherine D Gonzalez,et al.  IL28B polymorphisms associated with therapy response in Chilean chronic hepatitis C patients. , 2011, World journal of gastroenterology.

[11]  F. Negro,et al.  Trends and projections of hepatitis C virus epidemiology in Latin America , 2011, Liver international : official journal of the International Association for the Study of the Liver.

[12]  S. Román,et al.  Epidemiología de las hepatitis virales en México , 2011 .

[13]  C. Thio,et al.  IL28B and the control of hepatitis C virus infection. , 2010, Gastroenterology.

[14]  M. Romero-Gómez,et al.  Interleukin‐28B genetic variants and hepatitis virus infection by different viral genotypes , 2010, Hepatology.

[15]  X. Lao,et al.  Replicated association between an IL28B gene variant and a sustained response to pegylated interferon and ribavirin. , 2010, Gastroenterology.

[16]  David B. Goldstein,et al.  Genetic variation in IL28B and spontaneous clearance of hepatitis C virus , 2009, Nature.

[17]  Jacques Fellay,et al.  Genetic variation in IL28B predicts hepatitis C treatment-induced viral clearance , 2009, Nature.

[18]  D. Kershenobich-Stalnikowitz,et al.  Prevalence of hepatitis C virus genotypes in Mexican patients. , 2007, Revista de gastroenterologia de Mexico.

[19]  J. Pawlotsky,et al.  Hepatitis C virus: virology, diagnosis and management of antiviral therapy. , 2007, World journal of gastroenterology.

[20]  Asociación Mexicana de Hepatología.  National Consensus of Hepatitis C. June 28-29, 2002. , 2002, Annals of hepatology.

[21]  T. Poynard,et al.  Meta‐analysis of interferon randomized trials in the treatment of viral hepatitis C: Effects of dose and duration , 1996, Hepatology.

[22]  R. Vázquez-Frias,et al.  Mexican consensus on the diagnosis and management of hepatitis C infection. , 2015, Annals of hepatology.

[23]  A ALBORNOZ PLATA,et al.  [Epidemiology of viral hepatitis]. , 1951, Pediatria de las Americas.